Effects of Chronic Renal Failure on Kidney Drug Transporters and Cytochrome P450 in Rats

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Drug Metabolism And Disposition

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/dmd.111.039115PMID 21525170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs

  2010cited by this paper
• Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1.

  2010cited by this paper
• Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state

  2010cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Type 1 Sodium-dependent Phosphate Transporter (SLC17A1 Protein) Is a Cl−-dependent Urate Exporter*

  2010cited by this paper
• Therapeutic implications of renal anionic drug transporters.

  2010cited by this paper
• Involvement of Mrp2/MRP2 in the species different excretion route of benzylpenicillin between rat and human

  2009cited by this paper
• Effects of 1alpha,25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivo.

  2009influential reference
• Mechanisms of renal anionic drug transport.

  2008cited by this paper
• Effects of Chronic Renal Failure on Liver Drug Transporters

  2008cited by this paper
• Downregulation of hepatic acetylation of drugs in chronic renal failure.

  2008cited by this paper
• Down-Regulation of Intestinal Drug Transporters in Chronic Renal Failure in Rats

  2007cited by this paper
• The Contribution of Organic Anion Transporters OAT1 and OAT3 to the Renal Uptake of Rosuvastatin

  2007influential reference
• Roles of Organic Anion Transporters in the Progression of Chronic Renal Failure

  2007influential reference
• Effects of renal failure on drug transport and metabolism.

  2006influential reference
• Molecular physiology of renal organic anion transporters.

  2006cited by this paper
• Differential Contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in Vivo Renal Uptake of Uremic Toxins in Rats

  2005cited by this paper
• Characterization of uremic toxin transport by organic anion transporters in the kidney.

  2004cited by this paper
• Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney.

  2004influential reference
• Cytochromes P450, drugs, and diseases.

  2003cited by this paper
• Molecular aspects of renal anionic drug transport.

  2002cited by this paper
• Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat.

  2002influential reference
• Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy.

  2002cited by this paper
• Downregulation of intestinal cytochrome p450 in chronic renal failure.

  2002cited by this paper
• Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.

  2002cited by this paper
• Downregulation of hepatic cytochrome P450 in chronic renal failure.

  2001cited by this paper
• Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure.

  2001cited by this paper
• Unidimensional Scale for Dementia

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2.

  2000influential reference
• Endothelin B receptor-mediated regulation of ATP-driven drug secretion in renal proximal tubule.

  2000cited by this paper
• Decreased in vivo metabolism of drugs in chronic renal failure.

  2000cited by this paper
• Cellular and molecular aspects of drug transport in the kidney.

  2000cited by this paper
• A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)

  1999cited by this paper
• mRNA distribution and membrane localization of the OAT‐K1 organic anion transporter in rat renal tubules

  1997cited by this paper
• Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients.

  1997cited by this paper
• Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.

  1994cited by this paper
• Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate.

  1994cited by this paper
• Establishment of renal proximal tubule cell lines by targeted oncogenesis in transgenic mice using the L-pyruvate kinase-SV40 (T) antigen hybrid gene.

  1993cited by this paper
• Loading dose of digoxin in renal failure.

  1980cited by this paper
• [Administration of digoxin].

  1976cited by this paper
• An improved method of digoxin therapy.

  1968cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• HFD-induced Alterations in Renal Tubular Oatp4c1-P-gp Transport Systems in Mice: Impact on Digoxin Renal Excretion and Gadolinium-Enhanced Radiological Manifestations

  2025cites this paper
• Indoxyl sulfate as a potential tubular function marker across kidney disease models.

  2025cites this paper
• Ultra‐Sensitive Quantification of Indoxyl Sulfate and 3‐Carboxy‐4‐Methyl‐5‐Propyl‐2‐Furanpropanoic Acid in Plasma Using Ultra‐Performance Liquid Chromatography Coupled to Quadrupole Time‐of‐Flight Mass Spectrometry

  2025cites this paper
• Drug Exposure in Chronic Kidney Disease: It Is Not Just About the Glomerular Filtration Rate

  2025cites this paper
• Metabolomics reveals alterations in gut-derived uremic toxins and tryptophan metabolism in feline chronic kidney disease

  2025cites this paper
• Linking TLR-7 Signaling to Downregulation of Placental P-Glycoprotein: Implications for Fetal Drug Exposure

  2025cites this paper
• Taurodeoxycholic acid impairs the function and expression of organic anion transporter 2 through farnesoid X receptor activation during acute kidney injury to chronic kidney injury transition.

  2025cites this paper
• Bupropion decreases plasma levels of asymmetric dimethylarginine and ameliorates renal injury by modulation of Ddah1, Oatp4c1, Oct2, and Mate1 in rats with adenine-induced chronic renal injury

  2025cites this paper
• Predicting OCT2/MATEs‐Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium)

  2025cites this paper
• Perceived Benefits and Perceived Barriers Toward Satisfaction of JKN-KIS Kidney Failure Patients with a Systems Approach

  2024cites this paper
• Recent Advances on the Regulations of Organic Anion Transporters

  2024cites this paper
• Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special populations, and the blood-brain barrier

  2024cites this paper
• Effect of X-ray irradiation on renal excretion of bestatin through down-regulating organic anion transporters via the vitamin D receptor in rats.

  2024cites this paper
• The Kidney–Gut Axis as a Novel Target for Nutritional Intervention to Counteract Chronic Kidney Disease Progression

  2024cites this paper
• Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters

  2023cites this paper
• Canadian Content in the Pages of Drug Metabolism and Disposition: A Comprehensive Historical Analysis

  2023cites this paper
• Tubular Dysfunction Impairs Renal Excretion of Pseudouridine in Diabetic Kidney Disease.

  2023cites this paper
• Spatiotemporal Landscape of Kidney Tubular Responses to Glomerular Proteinuria

  2023cites this paper
• Kidney Drug Transporters in Pharmacotherapy

  2023cites this paper
• A State-of-the-Science Review of Interactions of Per- and Polyfluoroalkyl Substances (PFAS) with Renal Transporters in Health and Disease: Implications for Population Variability in PFAS Toxicokinetics

  2023cites this paper
• Cysteine conjugates of acetaminophen and p-aminophenol are potent inducers of cellular impairment in human proximal tubular kidney HK-2 cells

  2023cites this paper
• Mechanistic Study on the Effect of Renal Impairment on the Pharmacokinetics of Vildagliptin and its Carboxylic Acid Metabolite

  2022cites this paper
• The Dual Roles of Protein-Bound Solutes as Toxins and Signaling Molecules in Uremia

  2022cites this paper
• Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective

  2022cites this paper
• Physiologically based pharmacokinetic combined JAK2 occupancy modelling to simulate PK and PD of baricitinib with kidney transporter inhibitors and in patients with hepatic/renal impairment.

  2022cites this paper
• Determining the Effects of Chronic Kidney Disease on Organic Anion Transporter1/3 Activity Through Physiologically Based Pharmacokinetic Modeling

  2022cites this paper
• Association of Proximal Tubular Secretory Clearance with Long-Term Decline in Cognitive Function

  2022cites this paper
• The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction

  2022influential citation
• A systematic review of the drug–drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies

  2022cites this paper
• Highly sensitive simultaneous quantification of indoxyl sulfate and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled with tandem mass spectrometry.

  2022cites this paper
• Examination of the emerging role of transporters in the assessment of nephrotoxicity

  2022cites this paper
• Renal and non-renal response of ABC and SLC transporters in chronic kidney disease

  2021influential citation
• Effects of AST‐120 on muscle health and quality of life in chronic kidney disease patients: results of RECOVERY study

  2021cites this paper
• High salt exacerbates acute kidney injury by disturbing the activation of CD5L/apoptosis inhibitor of macrophage (AIM) protein

  2021cites this paper
• Surgical Models of Laboratory Animals

  2021cites this paper
• Impact of kidney dysfunction on hepatic and intestinal drug transporters.

  2021cites this paper
• Changes of renal transporters in the kinetic process of VCM-induced nephrotoxicity in mice.

  2021cites this paper
• Membrane Carriers and Transporters in Kidney Physiology and Disease

  2021cites this paper
• Influence of vitamin D treatment on functional expression of drug disposition pathways in human kidney proximal tubule cells during simulated uremia

  2021cites this paper
• Hypouricemic agents reduce indoxyl sulfate excretion by inhibiting the renal transporters OAT1/3 and ABCG2

  2021cites this paper
• Potential interactions between uraemic toxins and drugs: an application in kidney transplant recipients treated with calcineurin inhibitors

  2021cites this paper
• Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination.

  2020cites this paper
• Drug Metabolism in Chronic Kidney Disease

  2020cites this paper
• Antioxidant and protective effect of Stachys pilifera Benth against nephrotoxicity induced by cisplatin in rats.

  2020cites this paper
• Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry.

  2020cites this paper
• Prediction of Kidney Drug Clearance: A Comparison of Tubular Secretory Clearance and Glomerular Filtration Rate.

  2020cites this paper
• Kidney Clearance of Secretory Solutes Is Associated with Progression of CKD: The CRIC Study.

  2020cites this paper
• Systematic Development and Verification of a Physiologically Based Pharmacokinetic Model of Rivaroxaban

  2019cites this paper
• Pharmacokinetics in children with chronic kidney disease

  2019cites this paper
• Simulation-Based Analysis of the Impact of Renal Impairment on the Pharmacokinetics of Highly Metabolized Compounds

  2019cites this paper
• [Cardiovascular drugs and renal function: Pitfall of renal adaptation].

  2019cites this paper
• Uremic solutes modulate hepatic bile acid handling and induce mitochondrial toxicity.

  2019cites this paper
• Xenobiotic Transporters in the Kidney: Function and Role in Toxicity.

  2019cites this paper
• Recovery of OATP1B Activity after Living Kidney Transplantation in Patients with End-Stage Renal Disease

  2019cites this paper
• Quantitative translation of microfluidic transporter in vitro data to in vivo reveals impaired albumin-facilitated indoxyl sulfate secretion in chronic kidney disease.

  2019cites this paper
• Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein

  2019cites this paper
• Renal organic anion transporters in drug–drug interactions and diseases

  2018cites this paper
• Alteration of renal excretion pathways in gentamicin‐induced renal injury in rats

  2018influential citation
• Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs

  2018cites this paper
• Prediction of the Effects of Renal Impairment on Clearance for Organic Cation Drugs that Undergo Renal Secretion: A Simulation-Based Study

  2018influential citation
• CHARACTERIZATION OF RENAL SECRETION IN RENAL TRANSPLANT PATIENTS

  2018cites this paper
• Elucidation of Substrate Binding Interactions for Human Organic Cation Transporters 1 (SLC22A1) and 2 (SLC22A2) Using In Silico Homology Modeling in Conjunction with In Vitro Site-Directed Mutagenesis and Kinetic Analysis

  2018cites this paper
• Effects of renal impairment on transporter‐mediated renal reabsorption of drugs and renal drug–drug interactions: A simulation‐based study

  2018cites this paper
• Disease‐Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium

  2018cites this paper
• Regulation of Drug Transporters by Inflammation

  2017cites this paper
• The in vivo effects of adenine-induced chronic kidney disease on some renal and hepatic function and CYP450 metabolizing enzymes.

  2017cites this paper
• Increased Plasma Exposures of Conjugated Metabolites of Morinidazole in Renal Failure Patients: A Critical Role of Uremic Toxins

  2017cites this paper
• Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP

  2017cites this paper
• Delineating the Role of Various Factors in Renal Disposition of Digoxin through Application of Physiologically Based Kidney Model to Renal Impairment Populations

  2017cites this paper
• Modulated function of multidrug resistance-associated proteins in cisplatin-induced acute renal failure rats.

  2017cites this paper
• Pharmacokinetics of metformin in the rat: assessment of the effect of hyperlipidemia and evidence for its metabolism to guanylurea.

  2017cites this paper
• Mechanism of insulin resistance in a rat model of kidney disease and the risk of developing type 2 diabetes

  2017cites this paper
• Pharmacokinetic/pharmacodynamic considerations for cancer patients undergoing hemodialysis

  2017cites this paper
• Impairment of the carnitine/organic cation transporter 1-ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease.

  2017cites this paper
• Loops and layers of post‐translational modifications of drug transporters☆

  2017cites this paper
• Modulation of P-glycoprotein Expression and Function under Disease States in Rats and Humans

  2017cites this paper
• Identification and Quantitative Assessment of Uremic Solutes as Inhibitors of Renal Organic Anion Transporters, OAT1 and OAT3.

  2016cites this paper
• Characterization of acetaminophen toxicity in human kidney HK-2 cells.

  2016cites this paper
• Posttranslational Regulation of Organic Anion Transporters by Ubiquitination: Known and Novel

  2016cites this paper
• Implications of Kidney Disease on Metabolic Reduction.

  2016cites this paper
• Physiological scaling factors and mechanistic models for prediction of renal clearance from in vitro data

  2016influential citation
• Conjugated metabolites represent the major circulating forms of Abelmoschus manihot in vivo and show an altered pharmacokinetic profile in renal pathology

  2016cites this paper
• Effects of Chronic Renal Failure on Brain Cytochrome P450 in Rats

  2016cites this paper
• Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation

  2016cites this paper
• The Effect of AST-120 on Hepatic Metabolism and Transport in Chronic Kidney Disease

  2016cites this paper
• Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.

  2016cites this paper
• The Preventive Effect of Vitamin C on Styrene-Induced Toxicity in Rat Liver and Kidney

  2015cites this paper
• Pharmacocinétique des médicaments en insuffisance rénale : nouveautés

  2015cites this paper
• Infection-mediated Modulation of Drug Transporters in Pregnancy; Implications for Fetal Drug Exposure

  2015cites this paper
• Regulation of Hepatic Drug Metabolizing Enzymes in Chronic Kidney Disease

  2015cites this paper
• Alterations in drug disposition in older adults

  2015cites this paper
• [Drug pharmacokinetics in renal failure: What's new?].

  2015cites this paper
• Altered Renal Expression of Relevant Clinical Drug Transporters in Different Models of Acute Uremia in Rats. Role of Urea Levels

  2015cites this paper
• CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease.

  2015cites this paper
• Protective Activity of Dendropanax Morbifera Against Cisplatin-Induced Acute Kidney Injury

  2015cites this paper
• Erythropoietin and Chronic Kidney Disease Alter Hepatic Expression of Cytochrome P450 Enzymes and Drug Transport Proteins

  2014influential citation
• Organic Anion Transporters

  2014cites this paper
• Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis

  2014cites this paper
• The kidney and uremic toxin removal: glomerulus or tubule?

  2014cites this paper
• Effects of Renal Impairment on the Pharmacokinetics of Morinidazole: Uptake Transporter-Mediated Renal Clearance of the Conjugated Metabolites

  2014influential citation